Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study
Por:
Dudnyk, A, Tytarenko, N, Andrada, IR, Lytvyniuk, O, Tolstova, O, Millet, JP, Casas, X, Antuori, A, Ciobanu, N, Crudu, V and Domínguez, J
Publicada:
6 mar 2026
Ahead of Print:
1 mar 2026
Resumen:
Purpose Phenotypic drug susceptibility testing (pDST) for Mycobacterium tuberculosis complex (MTC) is slow, and routine molecular assays detect only a subset of resistance-associated mutations. We aimed to assess the diagnostic accuracy of the TB Resistance DNA-Array (GenID GmbH, Germany) for detecting isoniazid (INH) and rifampicin (RIF) resistance, and to evaluate the added value of Deeplex (R) Myc-TB, a culture free, targeted next-generation sequencing (tNGS) from GenoScreen, France, for identifying drug resistance and resolving discrepancies with pDST. Methods Clinical samples from 234 individuals with bacteriologically confirmed pulmonary tuberculosis (TB) were analyzed: 98 (41.9%) from Ukraine, 25 (10.7%) from Moldova, and 111 (47.4%) from Spain. TB Resistance DNA-Array and tNGS results were compared with pDST and cross-evaluated to identify resistance-conferring mutations. Results Among 196 sputum specimens tested with the TB Resistance DNA-Array, 98 (50.0%) produced conclusive RIF results and 102 (52.0%) conclusive INH results. Among conclusive outputs, the assay showed high sensitivity and specificity for RIF (94.3% and 98.4%) and INH (95.7% and 94.6%). Deeplex (R) Myc-TB generated conclusive results for 24/30 (80.0%) sputum samples and 21/23 (91.3%) culture isolates from 53 individuals. tNGS demonstrated high sensitivity for INH and RIF (both > 97.0%) but misclassified 2 of 8 INH-susceptible cases and 2 of 9 RIF-susceptible cases as resistant, suggesting a potential risk of overtreatment with second-line drugs. For linezolid, tNGS showed perfect specificity (100%); however, 1 of 3 cases was falsely categorised as resistant. For fluoroquinolones, sensitivity and specificity were 90.0% and 83.3%, respectively. Conclusion The TB Resistance DNA-Array performed reliably for detecting RIF and INH resistance in sputum samples with conclusive results. Integration of tNGS can improve interpretative algorithms tailored to clinically relevant and region-specific resistance mutations.
Filiaciones:
:
Germans Trias i Pujol Res Inst IGTP, Badalona, Barcelona, Spain
Natl Pirogov Mem Med Univ, Dept TB Clin Immunol & Allergy, Vinnytsia, Ukraine
Serv Clin, Barcelona, Spain
Serv Clin, Garcia Marino St 4, Barcelona 08022, Spain
:
Germans Trias i Pujol Res Inst IGTP, Badalona, Barcelona, Spain
Odesa I I Mechnikov Natl Univ, Odesa, Ukraine
:
Germans Trias i Pujol Res Inst IGTP, Badalona, Barcelona, Spain
Univ Autonoma Barcelona, Dept Genet & Microbiol, Badalona, Barcelona, Spain
Lytvyniuk, O:
Natl Pirogov Mem Med Univ, Dept TB Clin Immunol & Allergy, Vinnytsia, Ukraine
Tolstova, O:
Reg Phthisiopulmonol Ctr, Microbiol Lab, Vinnytsia, Ukraine
Millet, JP:
Serv Clin, Barcelona, Spain
Inst Salud Carlos III, CIBER Epidemiol & Salud Publ, CIBEREESP, Madrid, Spain
Casas, X:
Serv Clin, Barcelona, Spain
:
Germans Trias i Pujol Res Inst IGTP, Badalona, Barcelona, Spain
Germans Trias i Pujol Univ Hosp, Microbiol Dept, Badalona, Barcelona, Spain
Ciobanu, N:
PMSI Inst Pneumol Chiril Draganiuc, Kishinev, Moldova
Nicolae Testemitanu State Univ Med & Pharm, Kishinev, Moldova
Crudu, V:
PMSI Inst Pneumol Chiril Draganiuc, Kishinev, Moldova
Nicolae Testemitanu State Univ Med & Pharm, Kishinev, Moldova
:
Germans Trias i Pujol Res Inst IGTP, Badalona, Barcelona, Spain
Univ Autonoma Barcelona, Dept Genet & Microbiol, Badalona, Barcelona, Spain
Inst Salud Carlos III, CIBER Enfermedades Respiratorias, CIBERES, Madrid, Spain
hybrid
|